Not Yet Recruiting
A Widely Inclusive, Hybrid-Decentralized Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS
NCT07589764
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis ALS, Central Nervous System Diseases, +9 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
- Temple University Philadelphia, Pennsylvania, United States